跳至主要内容
临床试验/NCT05227456
NCT05227456撤回2 期

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

Saskatchewan Health Authority - Regina Area1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2022年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
发起方
入组人数
3
试验地点
1
主要终点
Hysterectomy

研究概览

简要总结

The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.

详细描述

The researchers aim to determine whether use of etonogestrel implant in patients with failed endometrial ablation significantly decreases hysterectomy rate. Changes in pelvic pain and vaginal bleeding will be assessed. Time to hysterectomy will be examined.

The researchers hypothesize that treatment of failed endometrial ablation with etonogestrel implant will decrease pelvic pain and vaginal bleeding resulting in a significantly decreased need for hysterectomy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Previous endometrial ablation
  • Pelvic pain and/or vaginal bleeding seeking treatment

排除标准

  • Previous or current VTE
  • Liver tumour, benign or malignant, or active liver disease
  • Undiagnosed abnormal genital bleeding
  • Known or suspected breast cancer
  • Uncontrolled hypertension
  • Allergy to component of etonogestrel implant
  • Lack of patient consent

研究组 & 干预措施

Etonogestrel implant

Experimental

The participants will receive an etonogestrel 68mg implant

干预措施: Etonogestrel 68mg implant (Device)

结局指标

主要结局

Hysterectomy

时间窗: Occurrence of hysterectomy will be documented any time during the 3 year follow up period

occurrence of hysterectomy

次要结局

  • Vaginal bleeding(PBAC score will be documented at baseline and 3, 6, 12, 18, 24, 30, and 36 months)
  • Pelvic Pain(VAS will be documented at baseline and 3, 6, 12, 18, 24, 30, and 36 months)
  • Time to Hysterectomy(Time of hysterectomy will be documented any time during the 3 year follow up period)

研究者

发起方
Saskatchewan Health Authority - Regina Area
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Smith

Obstetrician Gynecologist, Principal Investigator, Assistant Professor

Saskatchewan Health Authority - Regina Area

研究点 (1)

Loading locations...

相似试验